Health X Platform Limited

Healthcare · Healthcare Services

NSE: HEALTHX BSE: 533259
₹285.05
▲ 0.00 (0.00%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
33/100
Weak
Valuation
96/100
Undervalued
Momentum
29/100
Bearish

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹907 Cr
PE (TTM)
Data unavailable.
Price to Book
1.2
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
4.89%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-4.2
Relative return vs Sector, qtr %
-6.7
Free Cash Flow
₹-89 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
0.00%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-100.52%
as of March 31, 2019
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
144.89%
as of March 31, 2019
Industry median 18.84% (52 companies)
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
23.21
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
-5.34%
as of March 31, 2019
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
3.34%
as of June 30, 2013
Industry median 17.21% (61 companies)
Operating Margin (TTM)
88.36%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
-0.15%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
-0.19%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Return on equity is 15% or more (-0.2%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 283.6000 · High 290.9000
1W return
-2.8%
Low 275.0000 · High 296.4000
1M return
-5.4%
Low 275.0000 · High 319.0000
52W return
-8.4%
Low 252.5000 · High 363.0000
Lifetime High ₹562.0000 (Nov. 24, 2021)
Lifetime Low ₹17.6500 (Oct. 18, 2013)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
287.1
10D
290.4
20D
294.0
50D
298.9
100D
300.4
200D
296.8

Delivery and volume

Day avg. delivery
54.6%
Week avg. delivery
76.3%
Month avg. delivery
78.1%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

286.52
Pivot
First resistance289.43
Second resistance293.82
Third resistance296.73
First support282.13
Second support279.22
Third support274.83
Day RSI37.9
Day MFI12.5
Day MACD-4.15
Day MACD signal-2.78

Beta

1M0.59
3M0.28
1Y0.82
3Y0.80

Price change analysis

↓ -5.4%
Over 1 Month
LowHigh
275.00319.00
↓ -9.5%
Over 3 Months
LowHigh
275.00347.85
↑ 5.6%
Over 6 Months
LowHigh
264.00347.85
↓ -8.4%
Over 1 Year
LowHigh
252.50363.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-1 Cr
Basic EPS (June 30, 2026)
₹

Ranks #35 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.07%
  • FII/FPI2.29%
  • Other DII2.60%
  • Public21.04%

Largest holders

NameCategoryShares %Shares
Banwari Lal MittalPromoter33.9200%10791355
Topview Enclaves LLPPromoter24.7600%7877745
Luv Kush Projects LimitedPromoter11.9600%3805234
Ravi Kant SharmaPromoter2.3500%747393
Lekh Raj JunejaPublic1.8900%599990

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 74.84% to 74.07% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 2.17% to 2.29% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 93 insider trades, 1 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
1 Apr 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
27 Mar 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
23 Mar 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
19 Mar 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
16 Mar 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
13 Mar 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
20 Feb 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
16 Feb 2026 BANWARI LAL MITTAL Promoter Buy 0 ₹0
31 Dec 2025 BANWARI LAL MITTAL Promoter Buy 0 ₹0
17 Dec 2025 BANWARI LAL MITTAL Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
5 Sep 2025 AIRAVAT CAPITAL TRUST II Bulk Buy 364,148 273.0000 BSE
5 Sep 2025 AIRAVAT CAPITAL TRUST Bulk Sell 364,148 273.0000 BSE
25 Apr 2014 CHATURBHUJ ADVISORY SERVICES LLP Bulk Sell 181,691 28.0800 BSE
25 Apr 2014 BV ADVISORY SERVICES LLP Bulk Sell 225,000 28.0000 BSE
25 Apr 2014 TOPVIEW ENCLAVES LLP Bulk Buy 394,700 28.0100 BSE
4 Mar 2014 CHATURBHUJ ADVISORY SERVICES LLP Bulk Buy 177,874 23.0100 BSE
4 Mar 2014 BV ADVISORY SERVICES LLP Bulk Buy 223,532 23.0000 BSE
4 Mar 2014 BNP PARIBAS ARBITRAGE Bulk Sell 400,000 23.0000 BSE
28 Feb 2014 SARDARSINGH GOPALSINGH KARNAVAT Bulk Buy 170,000 21.6500 BSE
28 Feb 2014 RICHTIME TRADING COMPANY PRIVATE LIMITED Bulk Sell 170,000 21.6500 BSE

All bulk and block deals →

Ex-dateSubjectPer share (₹)Record date
23 Jul 2012 Annual General Meeting / Dividend Rs 1.00 Per Share 1.0000 —
25 Jul 2011 Annual General Meeting And Dividend Re.1/- Per Share 1.0000 —

Corporate Actions

Full history (16 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Microsec Financial Services Limited to Sastasundar Ventures Limited
—NAME_CHANGEName changed from Sastasundar Ventures Limited to HEALTH X PLATFORM LIMITED
23 Sep 2024OTHERAnnual General Meeting
22 Sep 2023OTHERAnnual General Meeting
21 Sep 2022OTHERAnnual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
7 Aug 2026 Financial Results Yes
30 May 2026 Financial Results Yes
6 Feb 2026 Financial Results Yes
13 Nov 2025 Financial Results Yes
12 Aug 2025 Financial Results Yes

Corporate Announcements

All 603 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Shareholders meeting Health X Platform Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
29 Sep 2026 AGM/EGM Health X Platform Ltd - 533259 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Health X Platform Ltd - 533259 - Disclosure Of Voting Results Of The 37Th AGM Of The Company In Terms Of Regulation 44 Of The SEBI (Listing Obligations And Disclosure Requirements) Reg, 2015
28 Sep 2026 Shareholders meeting Health X Platform Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
25 Sep 2026 Trading Window Health X Platform Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Health X Platform Ltd - 533259 - Closure of Trading Window
5 Sep 2026 Company Update Health X Platform Ltd - 533259 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 Copy of Newspaper Publication Health X Platform Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice of the 37th Annual General Meeting and e-voting information
4 Sep 2026 AGM/EGM Health X Platform Ltd - 533259 - Notice Of The 37Th Annual General Meeting Of The Company
4 Sep 2026 Others Health X Platform Ltd - 533259 - Business Responsibility and Sustainability Reporting (BRSR)

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Comfortable interest coverage (23.2x)
  • Strong revenue growth YoY (144.9%)

Weaknesses

  • Low Return on Equity (-0.2%)
  • Thin net profit margin (-5.3%)
  • Declining profit YoY (-100.5%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Health X Platform Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.